Colgate-Palmolive Financials - Benzinga

Colgate-Palmolive Co

CLNYSE

Trade with Public

Trade with Public

$86.06

0.740.87%

al cierre: Sep 25, 5:00 PM EST

$86.06

N/A

After hour: Sep 25, 4:35 PM EST

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

Colgate-Palmolive Financials

Colgate-Palmolive (CL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall

Colgate-Palmolive beats Q2 2026 earnings estimates, but North America weakness and tariff headwinds send CL stock lower. Read more.

Akanksha Bakshi

PRO
Colgate-Palmolive Affirms FY2026 Sales Guidance of $20.790B-$21.605B vs $21.463B Est

Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20.790 billion-$21.605 billion vs $21.463 billion estimate.

Benzinga Newsdesk

PRO
Colgate-Palmolive Q2 Adj. EPS $0.99 Beats $0.95 Estimate, Sales $5.361B Beat $5.358B Estimate

Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.95 by 4.21 percent. This is a 7.61 percent increase over earnings of $0.92 per share from the

Benzinga Newsdesk

Nasdaq Jumps Over 600 Points as MSFT Shares Surge: Investor Sentiment Improves, but Greed Index Remains in 'Fear' Zone

Improvement in market sentiment according to CNN Money Fear and Greed index. Dow Jones gains 600+ points, while Nasdaq ends losing streak.

Avi Kapoor

Amazon, Apple and 3 Stocks to Watch Heading Into Friday

U.S. stock futures higher, focus on Chevron, Apple, ExxonMobil, Amazon and Colgate-Palmolive earnings. Apple beats expectations.

Avi Kapoor

Top Wall Street Forecasters Revamp Colgate-Palmolive Expectations Ahead Of Q2 Earnings

Colgate-Palmolive Company (NYSE: CL) to release Q2 earnings on July 31, with analysts predicting EPS of 95 cents on revenue of $5.36 billion.

Avi Kapoor

© 2026 Benzinga | All Rights Reserved